Platelet Reactions and Immune Processes

Summary

We have studied the effect of complement inhibitors of various classes on platelet aggregation induced by collagen or by latex. The majority of the complement inhibitors which we studied inhibited collagen- or latex-induced platelet aggregation.

The possible role of complement as a mediator in the activation of platelet reactions is discussed.

These findings indicate that some chemicals are able to act on some of the immune reactions and also on platelet thrombogenetic reactions. It is suggested that drugs or combination of drugs having such a polyvalence might be of particular benefit in thrombo-immuno-inflammatory conditions.

• References

• 1 Jobin F, Tremblay F. Platelet reactions and immune processes. I. Activation of complement by several platelet-activating surfaces when coated with gammaglobulin; mechanism of complement fixation. Thrombos. Diathes. haemorrh. (Stuttg.) 22: 450 1969;
• 2 Mueller-Eckhardt C, Lüscher E. F. Immune reactions of human blood platelets. I. A comparative study on the effects on platelets of heterologous antiplatelet antiserum, antigen-antibody complexes, aggregated gammaglobulin and thrombin. Thrombos. Diathes. haemorrh. (Stuttg.) 20: 155 1968;
• 3 Packham M. A, Warrior E. S, Glynn M. F, Senyi A. S, Mustard J. F. Alteration of the response of platelets to surface stimuli by pyrazole compounds. J. exp. Med. 126: 111 1967;
• 4 Jobin F, Tremblay F. Platelet reactions and immune processes IV. The inhibition of complement by pyrazole compounds and other inhibitors of platelet reactions. (Manuscript in preparation).
• 5 Cushman W. F, Becker E. L, Wirtz G. Concerning the mechanism of complement action. III. Inhibitors of complement activity. J. Immunol. 79: 80 1957;
• 6 Mills S. E, Levine L. The inhibition of immune haemolysis by salicylaldoxime. Immunology 2: 368 1958;
• 7 Rodriguez E, Osier A. G. Studies on the inhibition of immune hemolysis by phlorizin. J. Immunol. 85: 347 1960;
• 8 Wirtz G. H, Becker E. L. Studies of the reaction between the sensitized erythrocyte and the first component of complement. Immunology 4: 473 1961;
• 9 Taylor F. B, Fudenberg H. Inhibition of the C’1 component of complement by aminoacids. Immunology 7: 319 1964;
• 10 Basch R. S. Inhibition of the third component of the complement system by derivatives of aromatic amino acids. J. Immunol. 94: 629 1965;
• 11 Becker E. L. Small molecular weights inhibitors of complement action. In: Complement. Ciba Foundation Symposium. edited by Wolstenholme G. E. W, and Knight J. 58. J. A. Churchill; London: 1965
• 12 Müller-Eberhard H. J. In discussion. In: Complement. Ciba Foundation Symposium. edited by Wolstenholme G. E. W, and Knight J. 73. J. A. Churchill; London: 1965
• 13 Neblett T. R, Burnham T. K, Kay N. Chloroquine: its mechanism of action upon immune phenomena. Arch. Derm. 92: 720 1965;
• 14 Müller-Eberhard H. J, Dalmasso A. P, Calcott M. A. The reaction mechanism of Blc-globu-lin (C’3) in immune hemolysis. J. exp. Med. 123: 33 1966;
• 15 Bladen H. A, Gewurz H, Mergenhagen S. E. Interactions of the complement system with the surface and endotoxic lipopolysaccharide of veillonella alcalescens. J. exp. Med. 125: 767 1967;
• 16 Shin H. S, Mayer M. M. The third component of the guinea pig complement system. III. Effect of inhibitors. Biochemistry 7: 3003 1968;
• 17 Glovsky M. M, Becker E. L, Halbrook N. J. Inhibition of guinea pig complement by maleo-pimaric acid and other derivatives of levopimaric acid. J. Immunol. 100: 979 1968;
• 18 Glynn M. F, Packham M. A, Hirsh J, Mustard J. F. The protein requirement for platelet surface interaction. J. clin. Invest. 45: 1013 1966;
• 19 Mustard J. F, Glynn M. F, Nishizawa E. E, Packham M. A. Platelet-surface interactions: relationship to thrombosis and hemostasis. Fed. Proc. 26: 106 1967;
• 20 Müller-Eckhardt G, Lüscher E. F. Immune reactions of human blood platelets. II. The effect of latex particles coated with gammaglobulin in relation to complement activation. Thrombos. Diathes. haemorrh. (Stuttg.) 20: 168 1968;
• 21 Packham M. A, Nishizawa E. E, Mustard J. F. Response of platelets to tissue injury. Bio-chem. Pharmacol. Suppl., p. 171 (1968).
• 22 Brecher G, Gronkite E. P. Morphology and enumeration of human blood platelets. J. appi. Physiol. 3: 365 1950;
• 23 Zucker M. B. In: Blood Platelets. Ed. Johnson S. A, Monto R. W, Rebuck J. W, and Horn R. G. 141. Little, Brown and Co.; Boston: 1961
• 24 O’Brien J. R. A comparison of platelet aggregation produced by seven compounds and a comparison of their inhibitors. J. clin. Path. 17: 275 1964;
• 25 Balinsky D, Davies D. D. Aromatic biosynthesis in higher plants 2. Mode of attachment of shikimic acid and dehydroshikimic acid to dehydroshikimic reductase. Biochem. J. 80: 296 1961;
• 26 O’Brien J. R. Platelet aggregation. II. Some results from a new method of study. J. clin. Path. 15: 452 1962;
• 27 Spaet T. H, Cintron J, Spivack M. Some properties of the platelet connective tissue mixed agglutination reaction. Proc. Soc. exp. Biol. (N.Y.) 111: 292 1962;
• 28 Born G. V. S, Gross M. J. The Aggregation of blood Platelets. J. Physiol. (Lond.) 168: 178 1963;
• 29 Mustard J. F, Hegardt B, Rowsell H. C, Macmillan R. L. Effect of adenosine nucleotides on platelet aggregation and clotting time. J. Lab. clin. Med. 64: 548 1964;
• 30 Glynn M. F, Movat H. Z, Murphy E. A, Mustard J. F. Study of platelet adhesiveness and aggregation, with latex particles. J. Lab. clin. Med. 65: 179 1965;
• 31 Haanen C, Holdrinet A. Blood platelet aggregation under various conditions and in some diseases. Exp. Biol. Med. 3: 164 1968;
• 32 Mayne E. E, Carville J. M. Enumeration of platelets using a model B counter. J. clin. Path. 22: 107 1969;
• 33 Herrmann R. G, Griggs V. G. Effect of counting solution and antihistaminics on platelet volume. Thrombos. Diathes. haemorrh. (Stuttg.) 18: 705 1967;
• 34 Jobin F, Tremblay F, Morissette M. Platelet reactions and immune processes III. The inhibition of platelet aggregation by chymotrypsin substrates and inhibitors. (Submitted for publication.)
• 35 Müller-Eberhard H. J. Chemistry and reaction mechanism of complement. Advanc. Immunol. 8: 1 1968;
• 36 Packham M. A, Mustard J. F. Effect of pyrazole compounds on thrombin-induced platelet aggregation. Proc. Soc. exp. Biol. (N.Y.) 130: 72 1969;
• 37 Mustard J. F, Glynn M. F, Murphy E. A, Packham M. A, Nishizawa E, Hirsh J, Hovig T, Jorgensen L. Platelet function and platelet economy. In: Biochemistry of Blood Platelets. Edited by Kowalski E, and Niewiarowski S. 133. Academic Press; London: 1967
• 38 Bounameaux Y, can Cauwenberge H. Action de la cortisone, de l’A. C.T.H., et du salicylate de soude sur les thrombocytes et la coagulation sanguine. Sang 25: 889 1954;
• 39 O’Brien J. R. Effects of salicylates on human platelets. Lancet I: 779 1968;
• 40 Evans G, Packham M. A, Nishizawa E. E, Mustard J. F, Murphy E. A. Effect of acetyl-salicylic acid on platelet function. J. exp. Med. 128: 877 1968;
• 41 Clayton S, Cross M. J. The aggregation of blood platelets by catecholamines and by thrombin. J. Physiol. 169: 82P 1963;
• 42 Schwartz C. J, Ardlie N. G. Catecholamines and platelet aggregation. Circulat. Res. 21 suppl. Ill: 187 1967;
• 43 Morissette M, Jobin F. Unpublished data.
• 44 Eastham R. D, Griffiths E. P. Reduction of platelet adhesiveness and prolongation of coagulation time of activated plasma by glyceryl guaiacolate. Lancet I: 795 1966;
• 45 Silverman J. L, Wurzel H. A. The comparative effects of glyceryl guaiacolate and adenosine on inhibition of ADP-induced platelet aggregation. Amer. J. med. Sci. 254: 491 1967;
• 46 Silverman J. L, Wurzel H. A. Effect of glyceryl guaiacolate on platelet function and other coagulation factors in vivo. Amer. J. clin. Path. 51: 35 1969;
• 47 Ward P. A, Becker E. L. The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase. J. exp. Med. 127: 693 1968;
• 48 Austen K. F, Brocklehurst W. E. Anaphylaxis in chopped guinea pig lung, I. Effect of peptidase substrates and inhibitors. J. exp. Med. 113: 521 1961;
• 49 Keller JR, Beeger I. Anaphylaxis in isolated rat mast cells. I. Effect of peptidase substrates and inhibitors. Int. Arch. Allergy 22: 31 1963;
• 50 Wilner G. D, Nossel H. L, Leroy E. C. Aggregation of platelets by collagen. J. clin. Invest. 47: 2616 1968;
• 51 Jerushalmy Z, Skoza L, Zucker M. B. Inhibition of ADP-induced platelet clumping. Fed. Proc. 24: 402 1965;
• 52 Salzman E. W, Chambers D. A. Inhibition of ADP-induced platelet aggregation by substituted amino acids. Blood 25: 602 1965;
• 53 O’Brien J. R. Effect of anti-inflammatory agents on platelets. Lancet I: 894 1968;
• 54 White J. G. Effects of colchicine and vinca alkaloids on human platelets 3. Influence on primary internal contraction and secondary aggregation. Amer. J. Path. 54: 467 1969;
• 55 Siqueira M, Nelson R. A. Platelet agglutination by immune complexes and its possible role in hypersensitivity. J. Immunol. 86: 516 1961;
• 56 Ishizaka T, Ishizaka K. Biological activity of aggregated gamma-globulin 5. Agglutination of erythrocytes and platelets. J. Immunol. 89: 709 1962;
• 57 Gocke D. J, Osier A. G. In vitro damage of rabbit platelets by an unrelated antigen-antibody reaction. II. Studies of the plasma requirement. J. Immunol. 94: 241 1965;
• 58 Barbaro J. F. The release of histamine from rabbit platelets by means of antigen-antibody precipitates. II. The role of plasma in the release of histamine. J. Immunol. 86: 377 1961;
• 59 Henson P. M. The adherence of leucocytes and platelets induced by fixed IgG antibody or complement. Immunology 16: 107 1969;
• 60 Henson P. M, Cochrane C. G. Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit platelets involving complement. J. exp. Med. 129: 167 1969;
• 61 Bettex-Gotland M, Lüscher E. F. Untersuchungen über die Auslösung der viskosen Metamorphose der menschlichen Blutplättchen durch Immunkomplexe. Path, et Microbiol. 27: 533 1964;
• 62 Shulman N. R. Immunoreactions involving platelets. III. Quantitative aspects of platelet agglutination, inhibition of clot retraction and other reactions caused by the antibody of quinidine purpura. J. exp. Med. 107: 697 1958;
• 63 Miescher P, Cooper N. The fixation of soluble antigen-antibody complexes upon thrombocytes. Vox Sang. 5: 138 1960;
• 64 Des Prez R. M, Bryant R. E. Two mechanisms of immunologically-induced injury to rabbit platelets. J. Immunol. 102: 241 1969;
• 65 Clark D. S, Poker J. E, Good R. A, Varco R. L. Humoral factors in canine renal allograft rejection. Lancet 1: 8 1968;
• 66 Najarian J. S, Perper R. J. Participation of humoral antibody in allogeneic organ transplantation rejection. Surgery 62: 213 1967;
• 67 McKenzie I. F. C, Whittingham S. Deposits of immunoglobulin and fibrin in human allografted kidneys. Lancet II: 1313 1968;
• 68 Gewurz H, Clark D. S, Finstad J, Kelly W. D, Varco R. L, Good R. A, Gabrielsen A. E. Role of the complement system in graft rejections in experimental animals and man. Ann. N. Y. Acad. Sci. 129: 673 1966;
• 69 Austen K. F, Russell P. S. Detection of renal allograft rejection in man by demonstration of a reduction in the serum concentration of the second component of complement. Ann. N. Y. Acad. Sci. 72 (09) 657 1966;
• 70 Dixon F. J. Shwartzman reaction after human renal homotransplantation. N. Engl. J. Med. 278: 642 1968;
• 71 Williams G. M, Hume D. M, Hudson R. P, Morris P. J, Kano K, Milgrom F. “Hyperacute” renal-homograft rejection in man. N. Engl. Med. J. 279: 611 1968;
• 72 Lowenhaupt R, Nathan P. Early accumulation of platelets in allotransplants of the dog kidney observed by electron microscopy. J. Cell Biol. 35: 83a 1967;
• 73 Lowenhaupt R, Nathan P. Platelet accumulation observed by electron microscopy in early phase of renal allotransplant rejection. Nature (Lond.) 220: 822 1968;
• 74 Mowbray J. F, Ellis E, Ackerman J. R. Evidence for reversible platelet aggregation in vessels as a cause of rejection episodes in human renal allografts. In: Proceedings of the First Int. Cong, of the Transplantation Society. Paris: 1967: 257.
• 75 Koffler D, Kunkel H. G. Mechanisms of renal injury in systemic lupus erythematosus. Amer. J.Med. 45: 165 1968;
• 76 Schur P. H, Sandson J. Immunological factors and clinical activity in lupus erythematosus. New Engl. J. Med. 278: 533 1968;
• 77 Townes A. S, Stewart C. R. Estimation of the second component and third component complex of complement in the serum of patients with systemic lupus erythematosus. Bull. Johns Hopk. Hosp. 117: 348 1965;
• 78 Cochrane C. G. Studies on the localization of circulating antigen-antibody complexes and other macromolecules in vessels. I. Structural studies. J. exp. Med. 118: 489 1963;
• 79 Kniker W. T, Cochrane C. G. The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces. J. exp. Med. 127: 119 1968;